Image pharmaphorum Editor Sales & Marketing Sponsored Go slow to go fast: Setting a content transformation journey... Pharma marketing is evolving and it’s evolving quickly. How can organisations successfully ride the wave of this transformation? Digital Frontiers Health 2024: Day Two We are back for Day Two of Frontiers Health, coming to you live from the heart of Berlin! Digital Frontiers Health 2024: Day One Welcome to our live coverage of Frontiers Health 2024 - Day One! Digital Frontiers Health 2024 Live Coverage Frontiers Health is back, bringing together healthcare innovators from around the world to exchange insights and discuss the hottest healthcare trends Load more results
Sales & Marketing Sponsored Go slow to go fast: Setting a content transformation journey... Pharma marketing is evolving and it’s evolving quickly. How can organisations successfully ride the wave of this transformation?
Digital Frontiers Health 2024: Day Two We are back for Day Two of Frontiers Health, coming to you live from the heart of Berlin!
Digital Frontiers Health 2024: Day One Welcome to our live coverage of Frontiers Health 2024 - Day One!
Digital Frontiers Health 2024 Live Coverage Frontiers Health is back, bringing together healthcare innovators from around the world to exchange insights and discuss the hottest healthcare trends
News MSD licenses Lp(a) heart drug from Hengrui in $2bn deal MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200m upfront.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl